Chronic urticaria (hives) continues to be a challenging disorder for dermatologists and allergists. Some patients go through years of hopping from one doctor to another, searching for a cause of their recurring welts (hives), itching, and often, swelling (angioedema). The frustration many people go through is immeasurable, as they endure a disease that is sporadic, prolonged and cosmetically embarrassing.
Chronic idiopathic urticaria (CIU) is a form of chronic hives, the cause of which remains unknown despite a full evaluation and laboratory testing. It is referred to as “chronic” once it lasts for six or more weeks either intermittently or continuously. CIU is rarely life-threatening, but the impact on the quality of life cannot be overstated. Work productivity, sleep quality, classroom attentiveness, social activities, sports and inter-personal relationships may all be affected by CIU .
The bad news is doctors may not be able to figure out the cause of your ...
Generic Name: EMOLLIENTS - TOPICAL Diaper Rash Relief Top Uses
This medication has 2 types of ingredients (emollient,
keratolytic) that work together to treat or prevent dry, rough, scaly, itchy
skin (e.g., eczema, keratosis, xerosis). Dry skin is caused by a loss of water
in the upper layer of the skin. Emollients are substances that soften and
moisturize the skin and decrease itching and flaking. Emollients/moisturizers
work by forming an oily layer on the top of the skin that traps water in the
skin. Petrolatum, lanolin, mineral oil, and dimethicone are common
Lactic acid, salicylic acid, and urea are keratolytics.
They increase moisture in the skin by softening/dissolving the horny substance
(keratin) holding the top layer of skin cells together. This helps the dead
skin cells fall off and helps the skin keep more water in. Higher strengths of
urea are used to treat corns, callous, and some nail problems (e.g., ingrow...
The medication sunitinib, which is approved for the treatment of kidney cancer and gastrointestinal stromal cancer, may also help patients with metastatic melanoma according to an article in the March, 2012 issue of Clinical Cancer Research. This new medication uses a patient's own tumor cells to create a customized treatment plan.
The drug recently completed Phase II clinical trials. During the testing is was shown to be effective in treating skin cancer which occurs on parts of the body not normally exposed to the sun, such as in the mouth, on the soles of the feet and the palms of the hand. This type of cancer has previously been difficult to treat because it is resistant to chemotherapy, with only 5 to 20 percent of patients responding well to it. The new drug, however, had a positive response in over one half of patients in the trial.
Sunitinib works by turning off a protein within the tumor. This protein is created by mutations within the genes and when "turned off...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.